Accelerate Diagnostics falls on reverse stock split announcement
** Shares of Accelerate Diagnostics Inc AXDX.O down 9% at
$0.75
** In-vitro diagnostics co announces reverse stock split at
a ratio of 1-for-10, to become effective on July 11
** Co says reverse stock split is intended to regain
compliance with the minimum bid price requirement of $1.00 per
share required to maintain continued listing on Nasdaq, among
other benefits
** AXDX shares up 6.9% YTD
(Reporting by Rupali Chaudhary in Bengaluru)
((Rupali.chaudhary@thomsonreuters.com))
Recent news on Accelerate Diagnostics
See all newsBrief: Accelerate Diagnostics Files For Chapter 11 Protection And Agrees To Terms To Sell Substantially All Assets
Brief: Accelerate Diagnostics files for Chapter 11 bankruptcy
Accelerate Diagnostics Inc expected to post a loss of 49 cents a share - Earnings Preview
Accelerate Diagnostics Inc reports results for the quarter ended December 31 - Earnings Summary
Accelerate Diagnostics Inc expected to post a loss of 49 cents a share - Earnings Preview